ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPTI Optibiotix Health Plc

16.25
-0.25 (-1.52%)
18 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -1.52% 16.25 15.50 17.00 16.50 16.25 16.50 113,459 13:48:32
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.72 14.82M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 16.50p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £14.82 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.72.

Optibiotix Health Share Discussion Threads

Showing 49951 to 49973 of 147750 messages
Chat Pages: Latest  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  Older
DateSubjectAuthorDiscuss
12/3/2019
17:05
Risky, even you must admit that if an RNS stated that the expected annual income from the Zeon contract was in the millions it would have a big impact on the share price.
imnotlong
12/3/2019
16:54
What would an update give that the official RNS hasn't already.? I've mentioned before, people do not know companies like Zeon & therefore immediately underestimate. A bit of work on who they supply & their status within India would lead to the conclusion it's a massive deal. U.K. cabinet ministers do not bother turning up unless it's substantial.
riskybusiness1
12/3/2019
16:44
success of India trip and his belief the deals they have in place will lead to Multi-£m Revs p.a. Indeed tens of £m's pa over time
nw99
12/3/2019
16:31
It already is signed.
imnotlong
12/3/2019
16:29
Once signed stock will roof it
nw99
12/3/2019
16:22
Huge news but no update from the company since the original RNS. Begs a question as to why.
imnotlong
12/3/2019
16:15
Huge news buying more
nw99
12/3/2019
15:31
https://lemminginvestors.blogspot.com/2019/03/optibiotix-health-passage-to-india.html?m=1I asked Stephen O'Hara if the "multimillion pound" value attributed to the deal by the British Trade Minister was per anum or life of the agreement?Stephen O'Hara: Given the interest and discussions we are having with major players we hope the deals we are striking in India will contribute to substantive revenues annually. Given the size of the India market, we would hope these would be multimillion annually, and over time 10's of millions.
riskybusiness1
12/3/2019
15:28
There has been an enormous amount of media coverage of the OPTI-ZEON deal in India. Here’s another website covering the story:



The media were there because it’s a big deal!

parob
12/3/2019
15:15
Agreed. If this was a Mickey Mouse deal of a few hundred grand there’s no way he’d be there getting papped and talking it up. It’s clear to see that this is a very large deal indeed. Here’s to many more over coming months!
colinzeal
12/3/2019
15:15
Rayrac, now that you are the self-proclaimed most knowledgeable poster on all things OPTI, could you point me to where it says "there were an awful lot of other life sciences companies represented there" and who were these companies?
Thanks in advance.


After New Delhi the Minister visited Mumbai where he met young entrepreneurs at the ‘Fintegrate Zone’ conference to further the UK’s position as a world leader in FinTech and position the UK as India’s partner of choice in raising finance. Among other engagements in Mumbai, he attended a multi-million pound UK-India life sciences deal signing; promoted UK-India sports links in the run up to the 2019 Cricket World Cup; and interacted with Indian youth leaders and Chevening alumni.

dire cons
12/3/2019
15:07
The U.K. government minister travelled to India specifically for the official Opti Zeon signing for a 'multimillion pound deal' between India & UK & somehow there's confusion over the relevance & who the beneficiaries are. That ones going on the growing list of ridiculous classics
riskybusiness1
12/3/2019
14:34
Anyone have any ideas when products with either Slimbiome or Lpldl will actually be on sale in India so these millions can start to flow to Opti? Still a year away or maybe less?
imnotlong
12/3/2019
14:04
Rayrac, do not forget that I will supply the gravy. DIAMOND.
diamond fibre
12/3/2019
13:58
#OPTI


Well well, so there’s a multi million life £ science signing. Why is everyone shy about its relevance too Opti? Surely we would have had some indication of that from soh by now?

Our friend Tom, though, wants us to pay for reading his interpretation of it!

It might be true of course, but there were an awful lot of life science companies represented there. It would be strange indeed if Opti were the sole beneficiaries of any multi million deal? Or even a fraction of a deal.

rayrac
12/3/2019
13:33
Blimey, I see that Rayrac has go two Likes.
Did he finally say something worthwhile??
John

2350220
12/3/2019
12:51
@ShareProphets 4m4 minutes agoJust posted: Has Tory Minister Mark Field announced a multi million pound deal for Optibiotix? https://www.shareprophets.com/41461 #OPTI
parob
12/3/2019
12:37
Not worth an rns then?
rayrac
12/3/2019
12:15
IPA appointment sees OptiBiotix pioneer a probiotic futurehTTp://optibiotix.com/ipa-appointment-sees-optibiotix-pioneer-a-probiotic-future/12TH MARCHCOMMERCIAL MEDIAOptiBiotix Health, a leading life sciences business focused on harnessing the power of the human microbiome, has announced the appointment of its Director of Business Development, Dr. Luis Gosálbez, as the second Chair to the Education and Communications Committee (ECC) of the International Probiotics Association (IPA).The appointment sees OptiBiotix gain influence throughout the life sciences sector and take a leading role in promoting a greater understanding of probiotic solutions, such as the firm's innovative Lactobacillus plantarum (LPLDL®) strain.Dr. Gosálbez commented: "The IPA is an internationally respected organisation currently working with its ECC to become the Global Voice of Probiotics?. The IPA allows more than one hundred healthcare and probiotics firms throughout Europe, Asia, Middle East & Africa, Oceania, South and North America, to talk to the future of probiotic health maintenance. The organisation works with government bodies alongside the industry to assist in establishing scientific standards for probiotics, pharmaceutical products and functional foods.""My presence on the Committee grants OptiBiotix exclusive access to IPA's professional scientific network, designed to grow probiotic intelligence and educate consumers and authorities on their proven health benefits. Our end of year meeting in Las Vegas evidenced the IPA's widespread popularity, with 2018 seeing a 26.6 per cent increase in members including pending membership applications. OptiBiotix and I are delighted to be part of this growing scientific community and look forward to networking with others in the business to pioneer a healthier future."Harnessing the microbiome-liver axis to positively impact upon the gut microbiome, OptiBiotix's lead probiotic strain Lactobacillus plantarum LPLDL®, demonstrates an exceptional capacity to modulate the metabolism of bile acids. This activity is important to bacterial survival in the hostile environment of the intestine, aiding conditions such as high blood pressure and high cholesterol, as well as physiological processes. LPLDL® has in human studies proven to lower total cholesterol levels by 36.7 per cent and offers a natural, scientifically founded alternative with no known side effects.
parob
12/3/2019
11:38
Colin - so true, clearly two way agreement & not just up to the management to 'cross the i's & dot the T's
riskybusiness1
12/3/2019
11:30
Do you have experience in signing contracts with large, multi-national companies, whitegold? My guess is you don't have a scooby. Deals will land when they land.
colinzeal
12/3/2019
09:03
SOH lives in a dream world? Pied piper?
rayrac
12/3/2019
08:33
Need good Tata news. Seems to be slow dotting the i.s and crossing the t's.
whitegold1
Chat Pages: Latest  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  Older

Your Recent History

Delayed Upgrade Clock